AAM
PFE icon

Alphadyne Asset Management’s Pfizer PFE Stock Holding History

Alphadyne Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,608
Closed -$138K – 340
2025
Q2 		$136K Buy
+5,608
New +$131K 0.02% 147
2023
Q4 		– Sell
-70,692
Closed -$2.34M – 143
2023
Q3 		$2.34M Buy
70,692
+55,780
+374% +$1.97M 0.18% 101
2023
Q2 		$547K Buy
+14,912
New +$580K 0.07% 81

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Alphadyne Asset Management's PFE Position: Q3 2025 in Review

Alphadyne Asset Management sold out of Pfizer (PFE) in Q3 2025, closing a stake of 5,608 shares — an estimated $138K sold.

Alphadyne Asset Management first reported a position in PFE in Q2 2023 and held it in 3 quarters. The position peaked at $2.34M in Q3 2023. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Alphadyne Asset Management reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Alphadyne Asset Management sold 5,608 Pfizer shares in Q3 2025, an estimated $138K.
  • Alphadyne Asset Management first reported a position in Pfizer in Q2 2023 and held it in 3 quarters.
  • Alphadyne Asset Management's Pfizer position peaked at $2.34M in Q3 2023.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Alphadyne Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.